These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Parkinson's disease: the case for novel treatment strategies. Stern MB; Freese A Exp Neurol; 1997 Mar; 144(1):2-3. PubMed ID: 9126142 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotection for Parkinson's disease: prospects and promises. Olanow CW; Schapira AH; Agid Y Ann Neurol; 2003; 53 Suppl 3():S1-2. PubMed ID: 12666093 [No Abstract] [Full Text] [Related]
10. The therapeutic effect of moclobemide, a reversible selective monoamine oxidase A inhibitor, in Parkinson's disease. Sternic N; Kacar A; Filipovic S; Svetel M; Kostic VS Clin Neuropharmacol; 1998; 21(2):93-6. PubMed ID: 9579294 [TBL] [Abstract][Full Text] [Related]
11. Rasagiline as a therapy for Parkinson's disease (PD). Hermanowicz N Am J Geriatr Pharmacother; 2007 Jun; 5(2):174-5; author reply 175-6. PubMed ID: 17719520 [No Abstract] [Full Text] [Related]
12. MAO-B inhibitors for the treatment of Parkinson's disease. Mov Disord; 2002; 17 Suppl 4():S38-44. PubMed ID: 12211138 [No Abstract] [Full Text] [Related]
13. Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links? Castagnoli K; Murugesan T Neurotoxicology; 2004 Jan; 25(1-2):279-91. PubMed ID: 14697903 [TBL] [Abstract][Full Text] [Related]
15. [Drug therapy of Parkinson's disease]. Myllylä V Duodecim; 1997; 113(18):1827-34. PubMed ID: 10892076 [No Abstract] [Full Text] [Related]
16. Rasagiline -- is there a place for this drug in managing Parkinson's disease? Sharma JC Int J Clin Pract; 2006 Feb; 60(2):132-3. PubMed ID: 16451281 [No Abstract] [Full Text] [Related]
17. [Neuroprotective and neurorestorative therapy in Parkinson's disease]. Jiménez-Jiménez FJ; Molina JA Rev Neurol; 1997 Aug; 25 Suppl 2():S185-93. PubMed ID: 9280687 [TBL] [Abstract][Full Text] [Related]
18. Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease. Naoi M; Maruyama W Expert Rev Neurother; 2009 Aug; 9(8):1233-50. PubMed ID: 19673610 [TBL] [Abstract][Full Text] [Related]
19. Rasagiline (Azilect) for Parkinson's disease. Med Lett Drugs Ther; 2006 Dec; 48(1249/1250):97-9. PubMed ID: 17149358 [No Abstract] [Full Text] [Related]
20. Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's disease. Stocchi F Int J Clin Pract; 2006 Feb; 60(2):215-21. PubMed ID: 16451296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]